CannabisNewsBreaks

MondaySep 24, 2018 10:25 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Claims Spot on CSE 25 Index

British Columbia-based fully-integrated cannabis company Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has been added to the Canadian Securities Exchange’s CSE 25 Index, effective September 21, 2018, at market close. Per the update, the index includes the top 25 securities in the CSE’s composite index ranked by market capitalization. “We are proud of our inclusion in the CSE 25 Index and being recognized as one of the top performers on the CSE,” Chris Bogart, president and CEO of Choom, stated in the news release. “Choom is committed to providing a growth opportunity for shareholders as…

Continue Reading

FridaySep 21, 2018 5:01 pm

CannabisNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Acquires WheresWeed.com

Golden Developing Solutions (OTCMKTS: DVLP), an emerging leader in the Cannabis sector, recently acquired Where’s Weed (Layer Six Media LLC DBA “Wheres Weed”), and its primary asset, WheresWeed.com. The site currently brings in more than 2.9 million page views per month. As a budding community-based online resource for cannabis consumers, Where’s Weed also offers a variety of user-friendly services, including a mobile app with over 80k downloads. “Where’s Weed is a perfect complementary piece of the puzzle for DVLP right now. The growth potential for this additional segment is enormous and will powerfully benefit from an infusion of capital. We…

Continue Reading

FridaySep 21, 2018 2:14 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH™, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH™ was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://cnw.fm/0l9eM). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,…

Continue Reading

FridaySep 21, 2018 2:07 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategically Employs R&D Strategy to Achieve Increased Productivity

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to give its investors more bang for their buck when it comes to research and development (“R&D”), as it has been proven that smaller companies achieve higher R&D productivity. A recent article discussing the company reads: “PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has taken this advice to heart. The health sciences company has three distinct research programs underway. Top of the line is a non-opioid pain treatment based on cannabinoids to be administered through a proprietary nose-to-brain, soluble gel (Sol-gel) drug delivery system. The research…

Continue Reading

FridaySep 21, 2018 1:46 pm

CannabisNewsBreaks – The Flowr Corp. and The Needle Capital Corp. Successfully Complete Qualifying Transaction

The Flowr Corp., a vertically-integrated Canadian licensed producer that focuses primarily on premium flower production, together with The Needle Capital Corp., this morning announced the successful completion of the qualifying transaction under the policies of the TSX Venture Exchange (the “TSXV”). In accordance with a business combination agreement entered into between Needle, Flowr and 2652253 Ontario Inc. ("Subco"), Needle and Flowr completed a transaction that resulted in a reverse takeover of Needle by the shareholders of Flowr to form the resulting issuer. Flowr and Needle attained conditional approval for the transaction from the TSXV on September 12, 2018 and the…

Continue Reading

FridaySep 21, 2018 9:30 am

CannabisNewsBreaks – Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) Applauds Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Commencement of Trading on the TSX Venture Exchange

Canopy Growth (TSX: WEED) (NYSE: CGC) recently congratulated the Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) team for its commencement of trading on the TSX Venture Exchange under the ticker symbol “RIV” on September 20, 2018. Canopy Rivers, a unique investment and operating platform designed to pursue investment opportunities in the emergent global cannabis sector, was originally founded to diversify Canopy Growth's cannabis supply streams. Canopy Rivers rapidly progressed into a worldwide strategic growth platform that builds value in cannabis venture partners by supporting each stage, from licensing and genetics to financial and strategic support, leveraging its affiliation with Canopy Growth.…

Continue Reading

ThursdaySep 20, 2018 4:51 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Initiates Trading on the TSX Venture Exchange

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a unique investment and operating platform designed to pursue investment opportunities in the emergent global cannabis sector, this morning began trading its subordinated voting shares on the TSX Venture Exchange under the ticker symbol "RIV." In a news release issued on September 17, 2018, Canopy Rivers reported the successful completion of its qualifying transaction. The transaction consisted of a three-cornered amalgamation involving the company’s wholly owned 10859150 Canada Inc. subsidiary merging with Canopy Rivers Corporation.  Canopy closed its first day of trading at $8.75 on volume of more than 18 million. To view the…

Continue Reading

ThursdaySep 20, 2018 2:08 pm

CannabisNewsBreaks – Canbiola, Inc. (CANB) Names New Medical Advisory Board Member

Canbiola (OTC PINK: CANB) today announced the addition of Dr. David J. Weissberg to the company’s medical advisory board. Dr. Weissberg also signed on as a private label customer. Today’s update agrees with Canbiola’s ongoing effort to attract and partner with global health and wellness industry experts. With over 25 years in private practice, Dr. Weissberg specializes in a meticulous and moderate approach to orthopedic care. He is also a co-owner of the Melville Surgery Center and certified in the ImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing) Protocol. “We are continuing to execute our plan to strengthen not only our…

Continue Reading

ThursdaySep 20, 2018 10:58 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces Development of New Line of CBD-Based Skin, Hair and Body Products

Cannabis Strategic Ventures, Inc. (OTC: NUGS) and True Promise Beauty this morning announced the development of LYXR, a new line of cannabidiol-based luxury skin, hair and body products. Per the update, LYXR products are developed from a line of hemp-derived phytocannabinoids and other natural ingredients that provide high-performing skin, hair and body topical solutions. The first product introduced for the LYXR line will be a facemask made from a CBD isolate. “For Cannabis Strategic Ventures, LYXR represents a tremendous opportunity to marry cannabis science with an increasing global demand for luxury personal care products,” Simon Yu, CEO of Cannabis Strategic…

Continue Reading

ThursdaySep 20, 2018 10:43 am

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Posts Update Regarding Recent Investment Amid Pending Hemp Bill Passage

Company management of Sugarmade (OTC: SGMD), a hydroponic supply company, this morning commented on its recent investment into the industrial hemp market as the pending Hemp Bill of 2018 appears to be on the verge of passage and enactment into federal law. The company believes the hemp portion of the farm bill will benefit Sugarmade and its shareholders if it passes. Sugarmade recently announced that it is committing capital to invest in Hempistry, Inc., a privately held Nevada corporation, which has started planting an ultra-high CBD industrial hemp strain in Kentucky. “Cultivation of hemp on the Kentucky site began in…

Continue Reading